Literature DB >> 26502983

Paget bone disease demonstrated on (68)Ga-PSMA ligand PET/CT.

C Artigas1, J Alexiou2, C Garcia3, Z Wimana3, F-X Otte4, T Gil5, R Van Velthoven6, P Flamen3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26502983     DOI: 10.1007/s00259-015-3236-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  5 in total

1.  Ivory fingers: monostotic Paget's disease of the phalanges.

Authors:  Edward Calif; Eugene Vlodavsky; Shalom Stahl
Journal:  J Clin Endocrinol Metab       Date:  2007-05       Impact factor: 5.958

2.  ⁶⁸Ga-PSMA imaging of metastatic breast cancer.

Authors:  Mike Sathekge; Moshe Modiselle; Mariza Vorster; Neo Mokgoro; Nozipho Nyakale; Brenda Mokaleng; Thomas Ebenhan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-05-01       Impact factor: 9.236

3.  Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.

Authors:  S S Chang; V E Reuter; W D Heston; N H Bander; L S Grauer; P B Gaudin
Journal:  Cancer Res       Date:  1999-07-01       Impact factor: 12.701

4.  A comparison of bone scanning and radiology in the assessment of patients with symptomatic Paget's disease.

Authors:  I Fogelman; D Carr
Journal:  Eur J Nucl Med       Date:  1980-10

5.  PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.

Authors:  A Afshar-Oromieh; A Malcher; M Eder; M Eisenhut; H G Linhart; B A Hadaschik; T Holland-Letz; F L Giesel; C Kratochwil; S Haufe; U Haberkorn; C M Zechmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-24       Impact factor: 9.236

  5 in total
  22 in total

1.  The Utility of [18F]DASA-23 for Molecular Imaging of Prostate Cancer with Positron Emission Tomography.

Authors:  Corinne Beinat; Tom Haywood; Yun-Sheng Chen; Chirag B Patel; Israt S Alam; Surya Murty; Sanjiv Sam Gambhir
Journal:  Mol Imaging Biol       Date:  2018-12       Impact factor: 3.488

2.  [68Ga]PSMA PET/CT Improves Initial Staging and Management Plan of Patients with High-Risk Prostate Cancer.

Authors:  Nader Hirmas; Akram Al-Ibraheem; Ken Herrmann; Abedalatif Alsharif; Haider Muhsin; Jamal Khader; Ali Al-Daghmin; Samer Salah
Journal:  Mol Imaging Biol       Date:  2019-06       Impact factor: 3.488

3.  Fibrous dysplasia mimicking bone metastasis on 68GA-PSMA PET/MRI.

Authors:  Liesbeth De Coster; Raf Sciot; Wouter Everaerts; Olivier Gheysens; Raf Verscuren; Christophe M Deroose; Steven Pans; Koen Van Laere; Karolien E Goffin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-05-09       Impact factor: 9.236

4.  68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0.

Authors:  Wolfgang P Fendler; Matthias Eiber; Mohsen Beheshti; Jamshed Bomanji; Francesco Ceci; Steven Cho; Frederik Giesel; Uwe Haberkorn; Thomas A Hope; Klaus Kopka; Bernd J Krause; Felix M Mottaghy; Heiko Schöder; John Sunderland; Simon Wan; Hans-Jürgen Wester; Stefano Fanti; Ken Herrmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06       Impact factor: 9.236

5.  A rare case of rectal carcinoma and prostate carcinoma with coexistent Paget's disease mimicking bone metastases in both 18F-FDG and 68Ga PSMA PET/CT.

Authors:  Arun Sasikumar; Ajith Joy; M R A Pillai; Vikraman Raman; Arun Vasudevan; Jayaprakash Madhavan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-10-04       Impact factor: 9.236

Review 6.  Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies.

Authors:  Emma E van der Toom; Haley D Axelrod; Jean J de la Rosette; Theo M de Reijke; Kenneth J Pienta; Kenneth C Valkenburg
Journal:  Nat Rev Urol       Date:  2019-01       Impact factor: 14.432

7.  Proposal for a Structured Reporting System for Prostate-Specific Membrane Antigen-Targeted PET Imaging: PSMA-RADS Version 1.0.

Authors:  Steven P Rowe; Kenneth J Pienta; Martin G Pomper; Michael A Gorin
Journal:  J Nucl Med       Date:  2017-09-08       Impact factor: 10.057

Review 8.  Looking for Drugs in All the Wrong Places: Use of GCPII Inhibitors Outside the Brain.

Authors:  James J Vornov; Diane Peters; Mike Nedelcovych; Kristen Hollinger; Rana Rais; Barbara S Slusher
Journal:  Neurochem Res       Date:  2019-11-20       Impact factor: 3.996

9.  [68Ga]Ga-PSMA-11 in prostate cancer: a comprehensive review.

Authors:  Frédéric Bois; Camille Noirot; Sébastien Dietemann; Ismini C Mainta; Thomas Zilli; Valentina Garibotto; Martin A Walter
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-12-15

10.  Imaging features of Paget's disease on 11C choline PET/CT.

Authors:  Cameron E Leitch; Ajit H Goenka; Benjamin M Howe; Stephen M Broski
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.